β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis.

MLA

Thenappan, Thenappan, et al. “β-Blocker Therapy Is Not Associated with Adverse Outcomes in Patients with Pulmonary Arterial Hypertension: A Propensity Score Analysis.” Circulation. Heart Failure, vol. 7, no. 6, Nov. 2014, pp. 903–10. EBSCOhost, https://doi.org/10.1161/CIRCHEARTFAILURE.114.001429.

APA

Thenappan, T., Roy, S. S., Duval, S., Glassner-Kolmin, C., & Gomberg-Maitland, M. (2014). β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis. Circulation. Heart Failure, 7(6), 903–910. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001429

Chicago

Thenappan, Thenappan, Samit S Roy, Sue Duval, Cherylanne Glassner-Kolmin, and Mardi Gomberg-Maitland. 2014. “β-Blocker Therapy Is Not Associated with Adverse Outcomes in Patients with Pulmonary Arterial Hypertension: A Propensity Score Analysis.” Circulation. Heart Failure 7 (6): 903–10. doi:10.1161/CIRCHEARTFAILURE.114.001429.